ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions (DDI+)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01765595
Recruitment Status : Completed
First Posted : January 10, 2013
Last Update Posted : October 21, 2014
Sponsor:
Information provided by (Responsible Party):
Leumit Health Services

January 9, 2013
January 10, 2013
October 21, 2014
January 2013
October 2014   (Final data collection date for primary outcome measure)
Hospital Admissions [ Time Frame: up to 12 months post initiation ]
Same as current
Complete list of historical versions of study NCT01765595 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions
Not Provided
Leumit Health Services, an health maintenance organization operating in Israel, will incorporate a web-based, decision support system for handling drug-drug interactions and drug information, termed DDI+. the investigators hypothesize that implementing such a system will reduce health-care expenditures (e.g., hospital admissions, referrals to ERs, Imaging procedures).
Not Provided
Interventional
Not Applicable
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Healthcare
Other: DDI+
  • Experimental: DDI+
    DDI+ Incorporated in routine ambulatory practice
    Intervention: Other: DDI+
  • No Intervention: Control
    Standard care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
715
150000
October 2014
October 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Number of chronic concomitant drugs ≥5

Exclusion Criteria:

  • Patients diagnosed with HIV/AIDS, and/or viral hepatitis B or C.
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT01765595
LHS012013
Not Provided
Not Provided
Not Provided
Leumit Health Services
Leumit Health Services
Not Provided
Principal Investigator: Abraham Weizman, MD Tel Aviv University
Leumit Health Services
October 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP